[1]
A. Ç. İnkaya, E. Türk Arıbaş, B. Kandemir, H. Acar, and M. Bitirgen, “Role of Tumor Necrosis Factor alpha promoter polymorphisms in interferon related side effects in chronic hepatitis B patients under interferon alpha 2b treatment”, Acta Medica, vol. 50, no. 2, pp. 32–38, Jun. 2019.